Clinical results with two different pharmaceutical preparations of riboflavin in corneal cross-linking: an 18-month follow up

BACKGROUND: Comparison of long-term clinical results of two different pharmaceutical formulations used in corneal cross-linking (CXL) in keratoconus patients. METHODS: Sixty eyes of 60 keratoconus patients underwent CXL in two groups. We used riboflavin preparations from Sina Darou, Iran in group A,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemi, Hassan, Seyedian, Mohammad Amin, Miraftab, Mohammad, Bahrmandy, Hooman, Sabzevari, Araz, Asgari, Soheila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314761/
https://www.ncbi.nlm.nih.gov/pubmed/25616392
http://dx.doi.org/10.1186/s40199-015-0091-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314761/
https://www.ncbi.nlm.nih.gov/pubmed/25616392
http://dx.doi.org/10.1186/s40199-015-0091-z

Ejemplares similares